• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Lupin Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3026.0
  • ISIN : INE326A01037
1,867.30 -62 (-3.20%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    1,860.70

  • Today’s High

    1,931.00

  • Open

    1,931.00

  • Perv Close

    1,929.10

  • 52W Low

    1,795.20

  • 52W High

    2,402.90

Key Indicators

  • P/E(TTM)

    21.30

  • Mar.Cap (₹Cr.)

    85,288.43

  • Div & Yield %

    0.64

  • Book Value(₹)

    531.55

  • Debt-Equity Ratio

    -3.20

  • AGM Date

    01-Aug-2025

  • EPS

    87.58

  • P/E Ratio

    21.30

Financials Ratios

  • Debt-Equity Ratio

    0.28

  • Mar.Cap (₹Cr.)

    85,288.43

  • RONW (%)

    14.47

  • ROCE (%)

    15.34

Score Board

  • Equity (₹ in Cr.)

    91.35

  • BV (₹)

    531.50

  • Sales( ₹ in Cr.)

    16,967.50

  • NP (in Cr.)

    4,000.16

  • NP Var(%)

    74.0

  • Div%

    600.0

  • CPS (₹)

    101.80

  • EPS (₹)

    87.60

  • Traded Value (₹ in Lakhs)

    85,203.93

  • 52 Week High

    2,402.90

  • 52 Week Low

    1,795.20

  • Price BSE

    1865.0

  • Price NSE

    1,867.00

  • Market Capital( in Cr.)

    85,203.93

  • P/C Ratio

    18.30

  • P/E Ratio

    21.30

  • Price Vs.BV

    87.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 16,967.50 14,666.50 11,258.83 11,771.67 11,055.93 11,025.66
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 16,967.50 14,666.50 11,258.83 11,771.67 11,055.93 11,025.66
Other Income 253.39 115.51 210.02 216.99 129.09 475.19
Stock Adjustments 38.35 15.93 -120.79 242.38 81.86 28.72
Total Income 17,259.24 14,797.94 11,348.06 12,231.04 11,266.88 11,529.57
EXPENDITURE :            
Raw Materials 4,963.57 5,041.16 4,676.90 4,709.64 4,264.17 4,235.99
Power and Fuel Cost 414.63 444.41 447.42 418.45 389.54 416.26
Employee Cost 2,312.07 2,095.51 1,934.14 1,918.16 1,695.86 1,703.22
Other Manufacturing Expenses 1,268.19 1,182.52 1,155.60 1,209.09 1,135.79 1,108.70
Selling and Administration Expenses 2,349.23 2,264.54 1,797.13 1,573.22 1,355.01 1,557.70
Miscellaneous Expenses 382.24 204.01 162.95 1,976.35 253.36 884.11
Employee Benefit Expenses 2,312.07 2,095.51 1,934.14 1,918.16 1,695.86 1,703.22
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 11,689.93 11,232.15 10,174.14 11,804.91 9,093.73 9,905.98
Operating Profit 5,569.31 3,565.79 1,173.92 426.13 2,173.15 1,623.59
Interest 84.50 56.35 98.44 73.47 40.62 52.59
Gross Profit 5,484.81 3,509.44 1,075.48 352.66 2,132.53 1,571.00
Depreciation 647.69 724.75 548.34 514.19 502.83 518.75
Profit Before Tax 4,837.12 2,784.69 527.14 -161.53 1,629.70 1,052.25
Current Tax 857.12 484.05 95.89 57.80 362.85 362.05
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 7.04 -25.45 6.04 -30.63 8.23 -37.35
Reported Net Profit 3,972.96 2,326.09 425.21 -188.70 1,258.62 727.55
Extraordinary Items -27.20 23.78 14.42 30.64 41.61 -425.63
Adjusted Net Profit 4,000.16 2,302.31 410.79 -219.34 1,217.01 1,153.18
Adjustment below Net Profit -14.47 -8.79 -1.39 2.42 -7.89 -135.66
P & L Balance brought forward 17,333.97 15,274.71 15,032.74 15,514.10 14,535.25 14,227.34
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 379.01 258.04 181.85 295.08 271.88 226.30
P & L Balance carried down 20,913.45 17,333.97 15,274.71 15,032.74 15,514.10 14,592.93
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 600.00 400.00 200.00 200.00 325.00 300.00
Dividend Per Share(Rs) 12.00 8.00 4.00 4.00 6.50 6.00
Earnings Per Share-Unit Curr 87.01 51.04 9.35 -4.15 27.74 16.06
Earnings Per Share(Adj)-Unit Curr 87.01 51.04 9.35 -4.15 27.74 16.06
Book Value 531.72 452.12 404.66 399.34 409.20 385.72
Book Value(Adj)-Unit Curr 531.72 452.12 404.66 399.34 409.20 385.72

Shareholding Pattern

  • Promoter Group

    46.90%

  • Public Share Holding

    53.10%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 1,286,394 1,286,394.00 1,286,394 1,286,394
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 1,286,394 0.28 1,286,394 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 207,194,390 45.37 207,194,390 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,725,730 1.25 5,725,730 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 1,000 0.00 1,000 1
Others 0 0.00 0 0
Sub Total 212,921,120 46.62 212,921,120 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 28,667 0.01 28,667 3
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 17,300 0.00 15,800 10
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 97,057,762 21.25 97,057,762 884
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 21,198,475 4.64 21,198,475 32
Mutual Funds / UTI 88,382,769 19.35 88,380,169 38
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 7,140,304 1.56 7,140,304 20
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 213,825,277 46.82 213,821,177 987
2] Non Institution
Bodies Corporate 1,256,624 0.28 1,250,624 1,060
Clearing Members 665 0.00 665 13
Directors of their Relatives 22,232 0.00 22,232 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 5,000 0.00 5,000 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,665,899 0.36 1,665,499 8,206
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 544,730 0.12 544,730 3,888
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 366,872 0.08 366,872 3
Individuals holding nominal share capital up to Rs. 1 lakh 23,519,137 5.15 23,006,196 272,304
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 14,456 0.00 14,456 20
Others 1,228,307 0.27 1,228,307 4
Sub Total 28,683,332 6.28 28,162,991 285,605
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 456,716,123 100.00 456,191,682 286,604

Company Background

Lupin LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Lupin Ltd
  • BSE Code : 3026.0
  • ISIN : INE326A01037

  • Incorporation Year

    1983

  • Registered Office

    Kalpataru Inspire 3rd Floor
    Off Western Exp HW Santacruz-E, Mumbai,
    Maharashtra-400055

  • Telephone

    91-22-6640 2323

  • FAX

    91-22-6640 8131

  • Chairman

    M D Gupta

  • Managing Director

    Nilesh Deshbandhu Gupta.

  • Company Secretary

    R V Satam

  • Auditor

    B S R & Co LLP/Makarand M Joshi & Company

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Lupin Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Lupin 1,865.45 17,220.89 16,967.50 21.45 21.32
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10